ALBERTDAVD Stock Overview
Manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Albert David Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,384.25 |
| 52 Week High | ₹1,753.95 |
| 52 Week Low | ₹1,000.60 |
| Beta | 0.44 |
| 1 Month Change | 0.058% |
| 3 Month Change | -6.18% |
| 1 Year Change | 32.09% |
| 3 Year Change | 101.18% |
| 5 Year Change | 220.02% |
| Change since IPO | 343.31% |
Recent News & Updates
Albert David's (NSE:ALBERTDAVD) Attractive Earnings Are Not All Good News For Shareholders
Nov 22
A Piece Of The Puzzle Missing From Albert David Limited's (NSE:ALBERTDAVD) 26% Share Price Climb
Aug 31Recent updates
Albert David's (NSE:ALBERTDAVD) Attractive Earnings Are Not All Good News For Shareholders
Nov 22A Piece Of The Puzzle Missing From Albert David Limited's (NSE:ALBERTDAVD) 26% Share Price Climb
Aug 31Albert David (NSE:ALBERTDAVD) Is Increasing Its Dividend To ₹11.50
Jul 30Albert David (NSE:ALBERTDAVD) Has Announced That It Will Be Increasing Its Dividend To ₹11.50
Jul 16We Think That There Are Issues Underlying Albert David's (NSE:ALBERTDAVD) Earnings
May 21Positive Sentiment Still Eludes Albert David Limited (NSE:ALBERTDAVD) Following 25% Share Price Slump
Mar 20The Market Lifts Albert David Limited (NSE:ALBERTDAVD) Shares 33% But It Can Do More
Jan 20Albert David (NSE:ALBERTDAVD) Will Pay A Dividend Of ₹9.00
Jul 04Albert David (NSE:ALBERTDAVD) Is Paying Out A Dividend Of ₹9.00
May 22Here's Why We Think Albert David (NSE:ALBERTDAVD) Is Well Worth Watching
Feb 14We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Albert David Limited's (NSE:ALBERTDAVD) CEO For Now
Sep 08Calculating The Intrinsic Value Of Albert David Limited (NSE:ALBERTDAVD)
Feb 06Do Fundamentals Have Any Role To Play In Driving Albert David Limited's (NSE:ALBERTDAVD) Stock Up Recently?
Jan 22
Why Albert David's (NSE:ALBERTDAVD) CEO Pay Matters
Jan 07Have Insiders Been Buying Albert David Limited (NSE:ALBERTDAVD) Shares?
Dec 23Here's Why Albert David's (NSE:ALBERTDAVD) Statutory Earnings Are Arguably Too Conservative
Dec 08Should You Or Shouldn't You: A Dividend Analysis on Albert David Limited (NSE:ALBERTDAVD)
Nov 23A Look At The Intrinsic Value Of Albert David Limited (NSE:ALBERTDAVD)
Nov 08Should Weakness in Albert David Limited's (NSE:ALBERTDAVD) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Oct 13Is Now The Time To Put Albert David (NSE:ALBERTDAVD) On Your Watchlist?
Sep 28What Does Albert David's (NSE:ALBERTDAVD) CEO Pay Reveal?
Sep 13Are Insiders Buying Albert David Limited (NSE:ALBERTDAVD) Stock?
Aug 28Should You Buy Albert David Limited (NSE:ALBERTDAVD) For Its Dividend?
Aug 10A Look At The Fair Value Of Albert David Limited (NSE:ALBERTDAVD)
Aug 10Albert David Limited (NSE:ALBERTDAVD) Might Not Be As Mispriced As It Looks
Jul 20Shareholder Returns
| ALBERTDAVD | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 3.1% | 1.0% | 1.6% |
| 1Y | 32.1% | 35.7% | 17.5% |
Return vs Industry: ALBERTDAVD underperformed the Indian Pharmaceuticals industry which returned 35.7% over the past year.
Return vs Market: ALBERTDAVD exceeded the Indian Market which returned 17.5% over the past year.
Price Volatility
| ALBERTDAVD volatility | |
|---|---|
| ALBERTDAVD Average Weekly Movement | 4.6% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: ALBERTDAVD has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: ALBERTDAVD's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1938 | 1,497 | Umesh Kunte | www.albertdavidindia.com |
Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India. It offers formulations for parenterals, oral/enteral, topical agents, and vision care products. The company exports its products to Latin American, Southeast Asian, and other African countries.
Albert David Limited Fundamentals Summary
| ALBERTDAVD fundamental statistics | |
|---|---|
| Market cap | ₹7.88b |
| Earnings (TTM) | ₹685.47m |
| Revenue (TTM) | ₹3.65b |
11.5x
P/E Ratio2.2x
P/S RatioIs ALBERTDAVD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALBERTDAVD income statement (TTM) | |
|---|---|
| Revenue | ₹3.65b |
| Cost of Revenue | ₹1.23b |
| Gross Profit | ₹2.42b |
| Other Expenses | ₹1.73b |
| Earnings | ₹685.47m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 120.11 |
| Gross Margin | 66.22% |
| Net Profit Margin | 18.77% |
| Debt/Equity Ratio | 0.6% |
How did ALBERTDAVD perform over the long term?
See historical performance and comparisonDividends
0.8%
Current Dividend Yield9%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/04 08:21 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Albert David Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kameswari V. S. Chavali | FirstCall Research |